#METABOLOMICS WORKBENCH Lu_Group_20220325_061043 DATATRACK_ID:3140 STUDY_ID:ST002130 ANALYSIS_ID:AN003484 PROJECT_ID:PR001349
VERSION             	1
CREATED_ON             	April 6, 2022, 7:17 pm
#PROJECT
PR:PROJECT_TITLE                 	Discovery and characterization of virulence associated functional metabolites in
PR:PROJECT_TITLE                 	Escherichia coli based on functional metabolomics strategy
PR:PROJECT_SUMMARY               	Discovery and characterization of virulence associated functional metabolites in
PR:PROJECT_SUMMARY               	Escherichia coli based on functional metabolomics strategy
PR:INSTITUTE                     	Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University
PR:LAST_NAME                     	Lu
PR:FIRST_NAME                    	Haitao
PR:ADDRESS                       	800 Dongchuan RD. Minhang District, Shanghai, Shanghai, 200240, China
PR:EMAIL                         	haitao.lu@sjtu.edu.cn
PR:PHONE                         	15221478139
#STUDY
ST:STUDY_TITLE                   	Discovery and characterization of virulence associated functional metabolites in
ST:STUDY_TITLE                   	Escherichia coli based on functional metabolomics strategy(pellets
ST:STUDY_TITLE                   	metabolomics-1)
ST:STUDY_SUMMARY                 	Bacterial metabolites are substrates of virulence factors of uropathogenic
ST:STUDY_SUMMARY                 	Escherichia coli (UPEC), but the mechanism underlying the role of functional
ST:STUDY_SUMMARY                 	metabolites in bacterial virulence from the perspective of small molecular
ST:STUDY_SUMMARY                 	metabolism is unclear. In the present study, we used a strategy of functional
ST:STUDY_SUMMARY                 	metabolomics integrated with bacterial genetics in attempt to decipher the
ST:STUDY_SUMMARY                 	mechanism of virulence formation in Escherichia coli (E. coli) from the
ST:STUDY_SUMMARY                 	viewpoint of small molecule metabolism. We identified the virulence-associated
ST:STUDY_SUMMARY                 	metabolome via analysis of the primary metabolome of the pathogenic UTI89 strain
ST:STUDY_SUMMARY                 	and the non-pathogenic MG1655 strain. Then, the iron-mediated virulence
ST:STUDY_SUMMARY                 	associated metabolome was identified by an iron fishing strategy. Also, the
ST:STUDY_SUMMARY                 	mechanism of siderophores in regulating pathogenicity in different environments
ST:STUDY_SUMMARY                 	was explored by investigating the effect of iron on siderophore biosynthesis.
ST:STUDY_SUMMARY                 	Finally, by knocking out genes related to siderophore biosynthesis, siderophore
ST:STUDY_SUMMARY                 	transport and iron utilization, siderophores dependent iron-regulating virulence
ST:STUDY_SUMMARY                 	associated metabolome, including 18 functional metabolites, was identified and
ST:STUDY_SUMMARY                 	verified to be involved in the regulation of bacterial virulence. Based on this
ST:STUDY_SUMMARY                 	we found that these functional metabolites regulated the virulence of E. coli by
ST:STUDY_SUMMARY                 	targeting multiple metabolic pathways in an iron-siderophores dependent manner.
ST:STUDY_SUMMARY                 	Moreover, a quantitative proteomics approach was implemented to further
ST:STUDY_SUMMARY                 	elucidate the mechanism of functional metabolites and functional proteins in
ST:STUDY_SUMMARY                 	modulating bacterial virulence. And our findings demonstrated that functional
ST:STUDY_SUMMARY                 	proteins regulated the virulence of E. coli by mediating iron binding,
ST:STUDY_SUMMARY                 	iron-siderophore transmembrane transport, and the biosynthesis and expression of
ST:STUDY_SUMMARY                 	functional metabolites. Interestingly, we found that functional metabolites
ST:STUDY_SUMMARY                 	enhance the virulence of E. coli by specifically modulating the key metabolic
ST:STUDY_SUMMARY                 	pathways involved in purine metabolism, proline metabolism, arginine metabolism
ST:STUDY_SUMMARY                 	and pyrimidine metabolism. Taken together, our study identified for the first
ST:STUDY_SUMMARY                 	time 18 functional metabolites regulating the of E. coli virulence, greatly
ST:STUDY_SUMMARY                 	enriching our understanding of the mechanism of functional metabolites that
ST:STUDY_SUMMARY                 	regulate the E. coli virulence by targeting primary metabolism, which will
ST:STUDY_SUMMARY                 	largely contribute to the development of new strategies to target
ST:STUDY_SUMMARY                 	virulence-based diagnosis and therapy of infections caused by different
ST:STUDY_SUMMARY                 	pathogens.
ST:INSTITUTE                     	Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University
ST:LAST_NAME                     	Lu
ST:FIRST_NAME                    	Haitao
ST:ADDRESS                       	800 Dongchuan RD. Minhang District, Shanghai, Shanghai, 200240, China
ST:EMAIL                         	haitao.lu@sjtu.edu.cn
ST:PHONE                         	15221478139
#SUBJECT
SU:SUBJECT_TYPE                  	Bacteria
SU:SUBJECT_SPECIES               	Escherichia coli
SU:TAXONOMY_ID                   	562
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	WT-0-1P	Treatment:standard growth conditions	RAW_FILE_NAME=WT-0-1P
SUBJECT_SAMPLE_FACTORS           	-	WT-0-2P	Treatment:standard growth conditions	RAW_FILE_NAME=WT-0-2P
SUBJECT_SAMPLE_FACTORS           	-	WT-0-3P	Treatment:standard growth conditions	RAW_FILE_NAME=WT-0-3P
SUBJECT_SAMPLE_FACTORS           	-	WT-0-4P	Treatment:standard growth conditions	RAW_FILE_NAME=WT-0-4P
SUBJECT_SAMPLE_FACTORS           	-	WT-0-5P	Treatment:standard growth conditions	RAW_FILE_NAME=WT-0-5P
SUBJECT_SAMPLE_FACTORS           	-	WT-0-6P	Treatment:standard growth conditions	RAW_FILE_NAME=WT-0-6P
SUBJECT_SAMPLE_FACTORS           	-	WT-10-1P	Treatment:10 μM iron supplementation	RAW_FILE_NAME=WT-10-1P
SUBJECT_SAMPLE_FACTORS           	-	WT-10-2P	Treatment:10 μM iron supplementation	RAW_FILE_NAME=WT-10-2P
SUBJECT_SAMPLE_FACTORS           	-	WT-10-3P	Treatment:10 μM iron supplementation	RAW_FILE_NAME=WT-10-3P
SUBJECT_SAMPLE_FACTORS           	-	WT-10-4P	Treatment:10 μM iron supplementation	RAW_FILE_NAME=WT-10-4P
SUBJECT_SAMPLE_FACTORS           	-	WT-10-5P	Treatment:10 μM iron supplementation	RAW_FILE_NAME=WT-10-5P
SUBJECT_SAMPLE_FACTORS           	-	WT-10-6P	Treatment:10 μM iron supplementation	RAW_FILE_NAME=WT-10-6P
SUBJECT_SAMPLE_FACTORS           	-	MG1655-0-1P	Treatment:standard growth conditions	RAW_FILE_NAME=MG1655-0-1P
SUBJECT_SAMPLE_FACTORS           	-	MG1655-0-2P	Treatment:standard growth conditions	RAW_FILE_NAME=MG1655-0-2P
SUBJECT_SAMPLE_FACTORS           	-	MG1655-0-3P	Treatment:standard growth conditions	RAW_FILE_NAME=MG1655-0-3P
SUBJECT_SAMPLE_FACTORS           	-	MG1655-0-4P	Treatment:standard growth conditions	RAW_FILE_NAME=MG1655-0-4P
SUBJECT_SAMPLE_FACTORS           	-	MG1655-0-5P	Treatment:standard growth conditions	RAW_FILE_NAME=MG1655-0-5P
SUBJECT_SAMPLE_FACTORS           	-	MG1655-0-6P	Treatment:standard growth conditions	RAW_FILE_NAME=MG1655-0-6P
SUBJECT_SAMPLE_FACTORS           	-	ybtS-0-1P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtS-0-1P
SUBJECT_SAMPLE_FACTORS           	-	ybtS-0-2P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtS-0-2P
SUBJECT_SAMPLE_FACTORS           	-	ybtS-0-3P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtS-0-3P
SUBJECT_SAMPLE_FACTORS           	-	ybtS-0-4P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtS-0-4P
SUBJECT_SAMPLE_FACTORS           	-	ybtS-0-5P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtS-0-5P
SUBJECT_SAMPLE_FACTORS           	-	ybtS-0-6P	Treatment:standard growth conditions	RAW_FILE_NAME=ybtS-0-6P
SUBJECT_SAMPLE_FACTORS           	-	BS-0-1P	Treatment:standard growth conditions	RAW_FILE_NAME=BS-0-1P
SUBJECT_SAMPLE_FACTORS           	-	BS-0-2P	Treatment:standard growth conditions	RAW_FILE_NAME=BS-0-2P
SUBJECT_SAMPLE_FACTORS           	-	BS-0-3P	Treatment:standard growth conditions	RAW_FILE_NAME=BS-0-3P
SUBJECT_SAMPLE_FACTORS           	-	BS-0-4P	Treatment:standard growth conditions	RAW_FILE_NAME=BS-0-4P
SUBJECT_SAMPLE_FACTORS           	-	BS-0-5P	Treatment:standard growth conditions	RAW_FILE_NAME=BS-0-5P
SUBJECT_SAMPLE_FACTORS           	-	BS-0-6P	Treatment:standard growth conditions	RAW_FILE_NAME=BS-0-6P
SUBJECT_SAMPLE_FACTORS           	-	entB-0-1P	Treatment:standard growth conditions	RAW_FILE_NAME=entB-0-1P
SUBJECT_SAMPLE_FACTORS           	-	entB-0-2P	Treatment:standard growth conditions	RAW_FILE_NAME=entB-0-2P
SUBJECT_SAMPLE_FACTORS           	-	entB-0-3P	Treatment:standard growth conditions	RAW_FILE_NAME=entB-0-3P
SUBJECT_SAMPLE_FACTORS           	-	entB-0-4P	Treatment:standard growth conditions	RAW_FILE_NAME=entB-0-4P
SUBJECT_SAMPLE_FACTORS           	-	entB-0-5P	Treatment:standard growth conditions	RAW_FILE_NAME=entB-0-5P
SUBJECT_SAMPLE_FACTORS           	-	entB-0-6P	Treatment:standard growth conditions	RAW_FILE_NAME=entB-0-6P
SUBJECT_SAMPLE_FACTORS           	-	iroA-0-1P	Treatment:standard growth conditions	RAW_FILE_NAME=iroA-0-1P
SUBJECT_SAMPLE_FACTORS           	-	iroA-0-2P	Treatment:standard growth conditions	RAW_FILE_NAME=iroA-0-2P
SUBJECT_SAMPLE_FACTORS           	-	iroA-0-3P	Treatment:standard growth conditions	RAW_FILE_NAME=iroA-0-3P
SUBJECT_SAMPLE_FACTORS           	-	iroA-0-4P	Treatment:standard growth conditions	RAW_FILE_NAME=iroA-0-4P
SUBJECT_SAMPLE_FACTORS           	-	iroA-0-5P	Treatment:standard growth conditions	RAW_FILE_NAME=iroA-0-5P
SUBJECT_SAMPLE_FACTORS           	-	iroA-0-6P	Treatment:standard growth conditions	RAW_FILE_NAME=iroA-0-6P
SUBJECT_SAMPLE_FACTORS           	-	irp1-0-1P	Treatment:standard growth conditions	RAW_FILE_NAME=irp1-0-1P
SUBJECT_SAMPLE_FACTORS           	-	irp1-0-2P	Treatment:standard growth conditions	RAW_FILE_NAME=irp1-0-2P
SUBJECT_SAMPLE_FACTORS           	-	irp1-0-3P	Treatment:standard growth conditions	RAW_FILE_NAME=irp1-0-3P
SUBJECT_SAMPLE_FACTORS           	-	irp1-0-4P	Treatment:standard growth conditions	RAW_FILE_NAME=irp1-0-4P
SUBJECT_SAMPLE_FACTORS           	-	irp1-0-5P	Treatment:standard growth conditions	RAW_FILE_NAME=irp1-0-5P
SUBJECT_SAMPLE_FACTORS           	-	irp1-0-6P	Treatment:standard growth conditions	RAW_FILE_NAME=irp1-0-6P
#COLLECTION
CO:COLLECTION_SUMMARY            	After 18h of culture, the sample pellet was isolated. The bacterial pellets
CO:COLLECTION_SUMMARY            	harvested from 50 mL of broth culture were mixed with 1.2 mL 80% ice-cold
CO:COLLECTION_SUMMARY            	methanol (added to internal standard 0.001mg/ml 4-chloro-DL-phenylalanine), then
CO:COLLECTION_SUMMARY            	vortexed for 30 s, and placed on dry ice for 30 min. The samples were
CO:COLLECTION_SUMMARY            	centrifuged at 18000 × g for 15 min at 4 °C. The frozen samples were ground
CO:COLLECTION_SUMMARY            	with beads and the homogenates were centrifuged at 18000 × g for 15 min at 4
CO:COLLECTION_SUMMARY            	°C. The supernatant was mixed with 800μL ice-cold acetonitrile, and then left
CO:COLLECTION_SUMMARY            	to stand for 20 minutes in an ice bath. After centrifugation at 18000 × g 4℃
CO:COLLECTION_SUMMARY            	for 15 min, the supernatant was removed and filtered through 0.22μm membrane.
CO:SAMPLE_TYPE                   	Bacterial cells
#TREATMENT
TR:TREATMENT_SUMMARY             	M63 medium (1.36% monopotassium phosphate, 0.2% ammonium sulfate, 0.024%
TR:TREATMENT_SUMMARY             	magnesium sulfate, 0.001% calcium chloride, and 0.0015% nicotinic acid) was used
TR:TREATMENT_SUMMARY             	to form MG1655 and UTI89 mutants. In addition, add ferric chloride solution to
TR:TREATMENT_SUMMARY             	the medium to prepare 10μM iron M63 medium, we cultured the wild UTI89 strain
TR:TREATMENT_SUMMARY             	in the presence of 10μM iron. The E. coli strain was incubated in LB-agar plate
TR:TREATMENT_SUMMARY             	for 12 hours, one colony was isolated to LB broth for further 4 hours
TR:TREATMENT_SUMMARY             	incubation, then diluted the solution into M63 medium at a ratio of 1:100 and
TR:TREATMENT_SUMMARY             	the cultures were incubated for another18 h at 37°C, 200rpm to culture E. coli.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	The bacterial pellets harvested from 50 mL of broth culture were mixed with 1.2
SP:SAMPLEPREP_SUMMARY            	mL 80% ice-cold methanol (added to internal standard 0.001mg/ml
SP:SAMPLEPREP_SUMMARY            	4-chloro-DL-phenylalanine), then vortexed for 30 s, and placed on dry ice for 30
SP:SAMPLEPREP_SUMMARY            	min. The samples were centrifuged at 18000 × g for 15 min at 4 °C. The frozen
SP:SAMPLEPREP_SUMMARY            	samples were ground with beads and the homogenates were centrifuged at 18000 ×
SP:SAMPLEPREP_SUMMARY            	g for 15 min at 4 °C. The supernatant was mixed with 800μL ice-cold
SP:SAMPLEPREP_SUMMARY            	acetonitrile, and then left to stand for 20 minutes in an ice bath. After
SP:SAMPLEPREP_SUMMARY            	centrifugation at 18000 × g 4℃ for 15 min, the supernatant was removed and
SP:SAMPLEPREP_SUMMARY            	filtered through 0.22μm membrane. For LC/MS based metabolomics analysis, the
SP:SAMPLEPREP_SUMMARY            	dried samples were dissolved in 200μL water and 5μL aliquots were analyzed.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Agilent 1290 Infinity
CH:COLUMN_NAME                   	Waters Acquity BEH HSS T3 (100 x 2.1mm, 1.8um)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Agilent 6495 QQQ
MS:INSTRUMENT_TYPE               	Triple quadrupole
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	Agilent MassHunter Workstation Data Acquisition Agilent MassHunter
MS:MS_COMMENTS                   	QualitativeAnalysis B.07.00 Agilent MassHunter Quantitative Analysis (for QQQ)
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	peak area
MS_METABOLITE_DATA_START
Samples	MG1655-0-1P	MG1655-0-2P	MG1655-0-3P	MG1655-0-4P	MG1655-0-5P	MG1655-0-6P	WT-10-1P	WT-10-2P	WT-10-3P	WT-10-4P	WT-10-5P	WT-10-6P	WT-0-1P	WT-0-2P	WT-0-3P	WT-0-4P	WT-0-5P	WT-0-6P	entB-0-1P	entB-0-2P	entB-0-3P	entB-0-4P	entB-0-5P	entB-0-6P	BS-0-1P	BS-0-2P	BS-0-3P	BS-0-4P	BS-0-5P	BS-0-6P	iroA-0-1P	iroA-0-2P	iroA-0-3P	iroA-0-4P	iroA-0-5P	iroA-0-6P	irp1-0-1P	irp1-0-2P	irp1-0-3P	irp1-0-4P	irp1-0-5P	irp1-0-6P	ybtS-0-1P	ybtS-0-2P	ybtS-0-3P	ybtS-0-4P	ybtS-0-5P	ybtS-0-6P
Factors	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:10 μM iron supplementation	Treatment:10 μM iron supplementation	Treatment:10 μM iron supplementation	Treatment:10 μM iron supplementation	Treatment:10 μM iron supplementation	Treatment:10 μM iron supplementation	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions	Treatment:standard growth conditions
Methylmalonic acid	15886.67533	14979.46953	16128.03831	19540.04755	16856.23819	16883.09491	864.6740949	873.935898	719.7583998	816.8343121	839.4984105	879.8371413																																				
N-Acetylglutamic acid	5894.307325	5161.855381	6700.462988	6868.011254	6397.570483	7511.019404	869.5037864	853.4397538	861.4746545	802.5332573	796.7948883	833.4401285																																				
Taurine	2060.916716	2010.204166	1933.325361	2170.547825	1944.057819	1742.306661	1114.605616	1119.20977	881.8938483	1001.459268	1125.187052	1121.289599	7276.752501	6308.136434	6535.738346	6478.212742	6169.148328	7159.749476	848.8529614	704.2515697	717.4215393	842.0849196	783.4161713	756.2393784	1217.893386	888.0209963	912.0445293	1366.454218	1215.239778	995.5158052	1266.418895	1358.848497	1291.906978	1295.890744	1388.118482	1368.700728	2009.450422	2416.265979	2240.568319	3125.42294	2403.866015	2846.577172	3415.678184	4063.329662	4004.709286	4080.76379	3666.177006	3960.079185
Succinic acid	18341.50987	18536.83868	19025.28018	19771.9967	18306.34377	17389.82842	364.0195446	413.8180616	284.3214529	247.9484219	354.2136957	271.4230512	781.1351289	753.8401569	828.9134793	859.6450979	829.7897251	742.6408176																														
Maleic acid	11239.81086	10489.16083	12215.52441	13152.15358	11210.19049	11520.87943	115.384283	82.35704228	92.32343829	102.7209452	116.0555979	64.44312808	5265.846938	6095.311298	5153.977666	6228.743294	4914.952111	6953.762017	617.012918	618.4684446	558.4148459	541.9167611	439.9402726	459.3907969	748.3873022	794.4554308	594.7816207	972.0749857	774.1223362	878.9350269	823.5319799	686.7394514	719.8318665	655.6956456	824.3973722	633.2966563	504.5440111	518.6202144	511.877982	617.7852263	522.5309579	496.4372689	472.0794004	416.6031663	408.0818319	422.1937869	395.815552	440.4002042
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	Molecular weight	RT (min)	m/z
Methylmalonic acid	118.09	2.74	117.02
Maleic acid	116.07	1.1	133
N-Acetylglutamic acid	189.17	1.88	188.05/128
Taurine	125.15	0.9	126
Succinic acid	118	2.31	117.02
METABOLITES_END
#END